Objective To summarize recent scientific advances in protein-derived soluble biomarkers of
osteoarthritis. Design A systematic search on the PubMed electronic database of clinical …

Blood and urine biomarkers in osteoarthritis – an update on... : Current Opinion in Rheumatology
Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen …

Objectives Osteoarthritis (OA) patient stratification is an important challenge to design
tailored treatments and drive drug development. Biochemical markers reflecting joint tissue …

Osteoarthritis (OA) of joints such as the knee and hip are very prevalent, and the number of
individuals affected is expected to continue to rise. Currently, conservative treatments after …

Objective To review articles reporting on the development of soluble biomarkers in
osteoarthritis (OA) over the past year. Design Two literature searches were conducted using …

Osteoarthritis (OA) is the most common form of arthritis resulting in joint discomfort and
disability, culminating in decline in life quality. Attention has been drawn in recent years to …

The extracellular matrix (ECM), composed of interlinked proteins outside of cells, is an
important component of the human body that helps maintain tissue architecture and cellular …

Objective To compare C-reactive protein (CRP) and matrix metalloproteinase-generated
neoepitope of CRP (CRPM) as biomarkers of inflammation and radiographic severity in …

We aimed to identify serum biomarkers that predict knee osteoarthritis (OA) before the
appearance of radiographic abnormalities in a cohort of 200 women. As few as six serum …

Introduction Osteoarthritis (OA) affects over 500 million people worldwide. OA patients are
symptomatically treated, and current therapies exhibit marginal efficacy and frequently carry …